Are we ready for prime-time Lp(a) assay standardization?
Lp(a) meeting Prof. Marcovina emphasizes the importance of considering apo(a) size polymorphism when measuring Lp(a) levels in patients and discusses the Lp(a) Standardization Program.
This lecture by Santica Marcovina was part of the EAS-endorsed satellite meeting "The imminent danger of Lp(a): Time to face the challenge" held prior to the 87th EAS congress in Maastricht
Santica Marcovina, Research Professor of Medicine and Director of the Northwest Lipid Metabolism and Diabetes Research Laboratories (NWRL), University of Washington, Seattle, WA, USA
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.